Innoviva Inc (INVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | INVA | LLY | NVO | JNJ | MRK |
| Company | Innoviva Inc | Eli Lilly and Company | Novo Nordisk A/S ADR | Johnson & Johnson | Merck & Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NYSE | NYSE |
| Open | 15.53 | 775.00 | 128.05 | 146.88 | 130.92 |
| High | 15.53 | 795.50 | 130.46 | 146.88 | 130.92 |
| Low | 14.94 | 767.66 | 127.49 | 144.53 | 128.98 |
| Last | 15.11 | 781.10 | 128.31 | 144.59 | 129.22 |
| Change | -0.43 | +43.90 | +1.43 | -2.23 | -0.90 |
| % Change | -2.77% | +5.95% | +1.13% | -1.52% | -0.69% |
| Volume | 925,200 | 7,437,100 | 7,841,000 | 8,817,700 | 6,944,900 |
| 20-Day Average Volume | 654,595 | 2,598,415 | 3,601,200 | 8,278,345 | 6,991,005 |
| Previous Close | 15.54 | 737.20 | 126.88 | 146.82 | 130.12 |
| Industry | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 14.83 | 752.12 | 125.46 | 148.58 | 127.36 |
| 20-Day Raw Stochastic | 61.57% | 81.35% | 75.17% | 9.79% | 56.87% |
| 20-Day Relative Strength | 51.68% | 58.69% | 55.39% | 33.47% | 58.03% |
| Weighted Alpha | +24.01 | +81.44 | +59.83 | -13.26 | +16.12 |
| Today's Opinion | 40% Buy | 80% Buy | 72% Buy | 100% Sell | 100% Buy |
| Previous Opinion | 56% Buy | 40% Buy | 72% Buy | 100% Sell | 100% Buy |
| Last Month's Opinion | 24% Buy | 88% Buy | 88% Buy | 24% Sell | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.40% since 04/23/24 | +4.75% since 04/23/24 | -0.26% since 04/23/24 | -3.32% since 04/23/24 | +1.84% since 04/23/24 |
| Low | 14.90 on 04/25/24 | 718.30 on 04/25/24 | 123.21 on 04/25/24 | 144.53 on 04/30/24 | 125.35 on 04/24/24 |
| High | 15.60 on 04/29/24 | 795.50 on 04/30/24 | 130.46 on 04/30/24 | 149.58 on 04/25/24 | 132.80 on 04/25/24 |
| 1-Month | |||||
| %Chg | -0.85% since 03/28/24 | +0.40% since 03/28/24 | -0.07% since 03/28/24 | -8.60% since 03/28/24 | -2.07% since 03/28/24 |
| Low | 14.32 on 04/16/24 | 718.30 on 04/25/24 | 121.79 on 04/16/24 | 143.13 on 04/18/24 | 124.50 on 04/18/24 |
| High | 15.60 on 04/29/24 | 795.50 on 04/30/24 | 130.46 on 04/30/24 | 158.15 on 04/01/24 | 132.80 on 04/25/24 |
| 3-Month | |||||
| %Chg | -8.26% since 01/30/24 | +21.10% since 01/30/24 | +17.69% since 01/30/24 | -8.93% since 01/30/24 | +6.21% since 01/30/24 |
| Low | 14.32 on 04/16/24 | 637.00 on 01/31/24 | 112.15 on 01/31/24 | 143.13 on 04/18/24 | 119.23 on 03/15/24 |
| High | 16.66 on 03/01/24 | 800.78 on 03/04/24 | 138.28 on 03/07/24 | 163.11 on 03/12/24 | 133.10 on 03/27/24 |
| 6-Month | |||||
| %Chg | +21.66% since 10/30/23 | +38.07% since 10/30/23 | +33.10% since 10/30/23 | -1.66% since 10/30/23 | +25.85% since 10/30/23 |
| Low | 12.22 on 11/01/23 | 547.61 on 10/31/23 | 94.73 on 12/11/23 | 143.13 on 04/18/24 | 99.80 on 11/29/23 |
| High | 16.86 on 01/04/24 | 800.78 on 03/04/24 | 138.28 on 03/07/24 | 163.58 on 01/22/24 | 133.10 on 03/27/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 955,360 | 742,173,056 | 575,795,264 | 348,430,528 | 327,317,888 |
| Shares Outstanding, K | 63,227 | 950,164 | 4,487,532 | 2,409,783 | 2,533,028 |
| Annual Sales | 310,460,000 | 34,124,100,000 | 33,724,300,000 | 85,159,000,000 | 60,115,000,000 |
| Annual Net Income | 179,720,000 | 5,240,400,000 | 12,150,770,000 | 35,153,000,000 | 365,000,000 |
| Last Quarter Sales | 85,840,000 | 9,353,400,000 | 9,526,160,000 | 21,383,000,000 | 15,775,000,000 |
| Last Quarter Net Income | 61,530,000 | 2,189,700,000 | 3,175,360,000 | 5,354,000,000 | 4,762,000,000 |
| 60-Month Beta | 0.57 | 0.34 | 0.41 | 0.53 | 0.38 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.76 on 02/29/24 | 2.49 on 02/06/24 | 0.71 on 01/31/24 | 2.71 on 04/16/24 | 2.07 on 04/25/24 |
| Latest Earnings Date | 05/14/24 | 04/30/24 | 05/02/24 | 04/16/24 | 04/25/24 |
| Most Recent Dividend | 0.250 on 09/08/15 | 1.300 on 02/14/24 | 0.663 on 03/22/24 | 1.190 on 02/16/24 | 0.770 on 03/14/24 |
| Next Ex-Dividends Date | 09/08/15 | 02/14/24 | 03/22/24 | 05/20/24 | 03/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 6.94 | 116.65 | 46.91 | 14.04 | 59.96 |